Tumor marker response to SARS-CoV-2 infection among patients with cancer.

We report temporary elevations of cancer tumor markers in the period surrounding COVID-19 infection. To our knowledge this is the first report of this phenomenon in cancer patients and has implications for clinical management and future research.